slotkoers
Bratislava S.E.
00:00:00 20-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
23
EUR
|
0,00%
|
|
0,00%
|
+5,50%
|
Fiscaal tijdperk: december |
2018
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
29,5
|
30,27
|
39,33
|
22,61
|
21,43
|
Bedrijfswaarde
1 |
28,08
|
25,29
|
37,18
|
20,47
|
18,35
|
K/w-verhouding
|
18,6
x
|
-
|
69
x
|
-19,6
x
|
41,3
x
|
Dividendrendement
|
5,83%
|
8,39%
|
1,25%
|
-
|
-
|
Marktkapitalisatie/omzet
|
0,99
x
|
1,71
x
|
4,42
x
|
2,05
x
|
1,32
x
|
Bedrijfswaarde/omzet
|
0,94
x
|
1,43
x
|
4,17
x
|
1,86
x
|
1,13
x
|
Bedrijfswaarde/EBITDA
|
9,47
x
|
5,91
x
|
17,7
x
|
87,4
x
|
12,5
x
|
Bedrijfswaarde/FCF
|
6,05
x
|
11,2
x
|
210
x
|
52,8
x
|
24,3
x
|
FCF Yield
|
16,5%
|
8,93%
|
0,48%
|
1,89%
|
4,12%
|
Price to Book
|
0,74
x
|
-
|
1,05
x
|
0,63
x
|
0,58
x
|
Aantal aandelen (in duizenden)
|
983
|
983
|
983
|
983
|
983
|
Referentieprijs
2 |
30,00
|
31,00
|
40,00
|
23,00
|
21,80
|
Datum van publicatie
|
24/04/19
|
29/04/22
|
29/04/22
|
28/04/23
|
25/04/24
|
Fiscaal tijdperk: december |
2018
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
29,89
|
17,65
|
8,908
|
11,03
|
16,18
|
EBITDA
1 |
2,964
|
4,279
|
2,104
|
0,2342
|
1,469
|
Bedrijfsresultaat (EBIT)
1 |
0,8334
|
2,158
|
0,4716
|
-1,078
|
0,1626
|
Operationele Marge
|
2,79%
|
12,23%
|
5,29%
|
-9,78%
|
1%
|
Resultaat voor belastingen (EBT)
1 |
1,475
|
2,728
|
0,5147
|
-0,8428
|
0,2214
|
Nettowinst (verlies)
1 |
1,128
|
2,276
|
0,4057
|
-0,8198
|
0,3691
|
Nettomarge
|
3,77%
|
12,9%
|
4,55%
|
-7,43%
|
2,28%
|
WPA
2 |
1,611
|
-
|
0,5796
|
-1,171
|
0,5273
|
Free Cash Flow
1 |
4,639
|
2,258
|
0,1771
|
0,3878
|
0,7564
|
FCF-marge
|
15,52%
|
12,79%
|
1,99%
|
3,52%
|
4,67%
|
Kasstroomconversie (ebitda)
|
156,51%
|
52,77%
|
8,42%
|
165,59%
|
51,47%
|
Kasstroomconversie (nettowinst)
|
411,35%
|
99,21%
|
43,65%
|
-
|
204,93%
|
Dividend per aandeel
2 |
1,750
|
2,600
|
0,5000
|
-
|
-
|
Datum van publicatie
|
24/04/19
|
29/04/22
|
29/04/22
|
28/04/23
|
25/04/24
|
Fiscaal tijdperk: december |
2018
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
1,41
|
4,97
|
2,15
|
2,14
|
3,09
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
4,64
|
2,26
|
0,18
|
0,39
|
0,76
|
ROE (netto-inkomsten/eigen vermogen)
|
3,88%
|
8,06%
|
1,48%
|
-3,14%
|
1,43%
|
ROA (netto-inkomsten/totale activa)
|
1,36%
|
4,1%
|
0,95%
|
-2,29%
|
0,35%
|
Totale activa
1 |
83,19
|
55,46
|
42,62
|
35,79
|
106,8
|
Nettoactief per aandeel
2 |
40,80
|
-
|
38,30
|
36,30
|
37,60
|
Cashflow per aandeel
2 |
5,880
|
-
|
3,300
|
3,060
|
4,410
|
Capex
1 |
0,47
|
1,47
|
0,25
|
0,7
|
1,09
|
Capex/omzet
|
1,56%
|
8,31%
|
2,82%
|
6,38%
|
6,74%
|
Datum van publicatie
|
24/04/19
|
29/04/22
|
29/04/22
|
28/04/23
|
25/04/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +5,50% | 17,49 mln. | | +22,35% | 44,12 mld. | | +22,22% | 22,61 mld. | | +17,81% | 15,11 mld. | | +15,73% | 13,61 mld. | | +57,91% | 13,34 mld. | | -8,98% | 6,94 mld. | | -0,05% | 6,79 mld. | | +15,65% | 5,75 mld. | | -8,87% | 5,73 mld. |
Generieke geneesmiddelen
|